Targeted Cellular Technology™
This unique, patented, five component process allows milligram quantities of neurotransmitter precursors to enter the cells and produce the required neurotransmitters. This process includes a neurotransmitter precursor, an uptake stimulator, a neuron activator, an adenosine brake inhibitor, and an attenuation releaser. Previous attempts to use neurotransmitter precursors have required much larger quantities of the precursors to elicit a therapeutic effect, making it functionally impossible for a patient to ingest gram quantities of a precursor on a daily basis. The use of the Targeted Cellular Technology process also prevents the development of tolerance. Unlike pharmaceutical agents that lose their effectiveness in a relative short period of time, Targeted Cellular Technology maintains its effectiveness and does not attenuate.
Overview of Neurotransmitter Science
Advanced Neurotransmitter Science
- TCT allows for the production of neurotransmitters from precursors
- Precursors in milligram quantities not gram quantities
- Amino acids that selectively produce neurotransmitter synthesis
- Reduced Attenuation
Amino Acids are the Precursors to Neurotransmitters
TCT (Targeted Cellular Technology)
- Neurotransmitter precursor
- Uptake stimulator
- Neuron activator
- Adenosine brake inhibitor
- Attenuation inhibitor
*Patent information:
- 7,674,482 Method and compositions for potentiating pharmaceuticals with amino acid based medical foods
- 7,601,369 Composition and method to augment and sustain neurotransmitter production
- 7,595,067 Composition and method to augment and sustain neurotransmitter production
- 7,585,523 Composition and method to augment and sustain neurotransmitter production
- 7,582,315 Composition and method to augment and sustain neurotransmitter production